Table 2.
Demographic and baseline characteristics
| Patient No. | Sex | Age, years | Migraine Type | Number of Attacks per Month | Pain Intensity (VAS) Score | Number of Headache Days per Month | MIDAS Grade (score) | BDI Score | Prophylactic Medications | Acute Medications + Time to Achieve Pain Relief | BMI, kg/m2 | Global PSQI Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | f | 36 | EM+ | 6 | 6 | 10 | III (18) | 18 | 4 Classes + Mg + Botox® | Triptan + 60 min | 24 | 5 |
| 2 | f | 66 | CM- | 6 | 8 | 20 | IV (45) | 19 | 4 Classes + Botox | NSAID + 90 min | 23 | 12 |
| 3 | f | 41 | CM- | 7 | 8 | 20 | IV (39) | 34 | 4 Classes | Triptan + 60 min | 31 | 12 |
| 4 | m | 70 | CM- | 7 | 7 | 15 | IV (39) | 15 | Calcium channel blocker | NSAID + 45 min | 25 | 2 |
| 5 | f | 56 | CM+ | 17 | 8 | 18 | IV (51) | 17 | N/A | Triptan + 60 min | 25 | 17 |
| 6 | f | 60 | CM- | 8 | 8 | 22 | IV (44) | 16 | 4 Classes + Botox | Triptan + 60 min | 24 | 7 |
| 7 | f | 35 | EM- | 4 | 8 | 9 | III (19) | 8 | 4 Classes + Botox | Triptan + 60 min | 17 | 8 |
| 8 | m | 50 | EM- | 5 | 7 | 9 | IV (37) | 23 | 4 Classes + Botox | NSAID + 160 min | 40 | 6 |
| 9 | f | 50 | EM- | 3 | 9 | 9 | IV (45) | 5 | 4 Classes + Botox | Triptan + 30 min | 22 | 7 |
| 10 | f | 35 | CM- | 12 | 8 | 15 | IV (36) | 11 | 4 Classes + Botox | Triptan + 60 min | 22 | 12 |
| 11 | m | 39 | EM- | 4 | 8 | 12 | III (19) | 21 | Calcium channel blocker + Mg + Ca++ | NSAID + 150 min | 29 | 7 |
| 12 | f | 52 | EM- | 4 | 8 | 12 | III (19) | 21 | 4 Classes + Mg | Triptan + 150 min | 23 | 3 |
| 13 | f | 45 | CM- | 15 | 8 | 18 | IV (33) | 25 | 4 Classes + Botox | NSAID + 45 min | 23 | 17 |
| 14 | f | 54 | EM- | 4 | 8 | 12 | III (18) | 17 | 4 Classes + Mg | Triptan + 120 min | 25 | 4 |
| 15 | f | 60 | EM- | 10 | 8 | 14 | III (19) | 18 | 4 Classes + Mg | Triptan + 60 min | 18 | 5 |
| 16 | f | 60 | EM- | 5 | 7 | 14 | III (16) | 16 | 4 Classes + Botox | Triptan + 120 min | 20 | 11 |
| 17 | f | 59 | CM+ | 10 | 8 | 15 | III (18) | 16 | 4 Classes + Botox | Triptan + 90 min | 22 | 6 |
| 18 | m | 72 | CM- | 9 | 8 | 18 | III (17) | 15 | 4 Classes | NSAID + 90 min | 22 | 8 |
| 19 | f | 60 | CM- | 6 | 8 | 20 | IV (44) | 16 | 4 Classes + Botox | Triptan + 60 min | 24 | 6 |
| 20 | f | 62 | EM- | 4 | 7 | 12 | III (16) | 15 | 4 Classes + Botox | Triptan + 120 min | 20 | 10 |
Abbreviations: BDI Beck Depression Inventory, BMI body mass index, Ca ++ calcium, CM chronic migraine, EM episodic migraine, f/m female/male, Mg magnesium, MIDAS Migraine Disability Assessment, NSAID nonsteroidal anti-inflammatory drug, PSQI Pittsburgh Sleep Quality Index, VAS visual analogue scale, 4 Classes β-blocker, anticonvulsant, tricyclic antidepressant, calcium channel blocker, −/+ without aura/with aura